The FDA has approved Eli Lilly's Zepbound to treat moderate to severe obstructive sleep apnea in adults with obesity.
MIT engineers have revealed a new gastric balloon design that can inflate on demand to make you feel full before meals.
A groundbreaking Harvard study reveals that semaglutide could benefit more people in the U.S. than ever imagined.
